Host-response biomarkers for precision tuberculosis: from immune transcriptomic signatures to clinical risk stratification
Tuberculosis (TB) remains a major infectious cause of morbidity and mortality, while current diagnostic and treatment-monitoring pathways remain largely pathogen-centered. Microbiological tests are indispensable for confirming TB and detecting drug resistance, but they do not directly measure host inflammatory activity...